Cian Healthcare Private Limited, a Pune based company engaged in the manufacturing of pharmaceutical, nutraceutical, ayurvedic, cosmeceuticals, sexual wellness, and food supplement products, is issuing the IPO (Initial Public Offering). Equity shares of face value Rs 10 are being offered during the issue at a price of Rs 65 per equity share including a premium of Rs 61, In this issue, 62,16,000 equity shares worth Rs 40 crore are to be launched. Cian Healthcare IPO issue opens on 2nd May 2019 and it closes on 9th May 2019. After allocation, the shares will be listed on the SME platform of BSE (Bombay Stock Exchange).
About Cian Healthcare Private Limited
Cian Healthcare Private Limited was established in Pune, Maharashtra in the year 2003. It is primarily engaged in the business of manufacturing a wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness, and Food supplement products. It is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing company equipped with full-fledged F & D and regulatory department. It develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing their engagements in specialist and super specialist division. It works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies.
This company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. It has a special licence for manufacturing veterinary products for the client like SAVAvet and Venky’s. Cian has developed more than 1,000 formulations and 2000 brands for the domestic market under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals. The company’s total revenue as restated in Financial Year 2018, 2017 and 2016 was ₹ 5,941.70 lakhs, ₹ 5,178.32 lakhs and ₹ 4,668.21 lakhs, respectively. Its profit/loss after tax as restated in Financial Year 2018, 2017 and 2016 was ₹ 375.65 lakhs, ₹ 223.64 lakhs and ₹ 137.20 lakhs, respectively.
Cian Healthcare IPO – Issue Details
| Issue Type | Fixed Price IPO Issue |
|---|---|
| Issue Opens | 2nd May 2019 |
| Issue Closes | 9th May 2019 |
| Face Value | Rs 10 Per Equity Share |
| Issue Price | Rs 61-65 Per Equity Share |
| Issue Size | 62,16,000 Equity Shares (Rs 40 crores) |
| Market Lot | 2,000 Shares |
| Minimum Order Quantity | 2,000 Shares |
| Listing | BSE SME |
Cian Healthcare IPO – Objects of the Issue
The following are the objects this upcoming IPO Issue:-
- Upgradation of existing plant i.e. Unit 1 situated at Roorkee, Uttarakhand, India.
- Margin money for setting up of manufacturing facility i.e. unit 2 situated at Roorkee, Uttarakhand, India.
- Enhancement of the company’s brand through advertising and other brand-building activities.
- Long-term working capital requirements.
- Acquisitions and other strategic initiatives.
- General corporate purposes.
Cian Healthcare Private Limited – Company Contact Details
Registered Office: Milkat No. 3339, Block No.1, From South Side, C.S.No.227 /2 + 3A, Harpale Park, Opp Berger Paint, Phursungi, Pune- 412308.
Telephone: +91-20-41471234 /265
Website: www.cian.co
Cian Healthcare IPO – Lead Manager of the Issue
The lead Manager to this IPO issue is Fedex Securities Private Limited.
Cian Healthcare IPO – Registrar of the Issue
The registrar of this IPO issue is Bigshare Services Private Limited.
Cian Healthcare IPO Issue Prospectus
Click here to read the Red Herring Prospectus of this IPO Issue.
Follow us on Facebook, LinkedIn, and Twitter to get the latest posts.
Disclaimer: This post is just information about the issue. It does not give any advice or recommendation. Investments into securities are subject to market risk. Please read the offer document carefully before investing. It is also advised to consult your financial advisor of necessary suggestions.
Tags: #IPO #Stock Market #Cian Healthcare IPO #Cian Healthcare Private Limited
